Across TCGA pan-cancer cohorts, RNU6-489P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNU6-489P data layer.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher RNU6-489P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-489P expression acts as an unfavorable survival marker.
KIRP and THCA are the cancer types where RNU6-489P RNA most reproducibly stratifies survival.